FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 78 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q3 2018. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,345,000 | -60.2% | 234,745 | -65.2% | 0.05% | -59.7% |
| Q2 2018 | $3,377,000 | -2.3% | 674,002 | 0.0% | 0.12% | -0.8% |
| Q1 2018 | $3,458,000 | +14.8% | 674,002 | +34.5% | 0.12% | +0.8% |
| Q4 2017 | $3,011,000 | -33.6% | 501,000 | -38.7% | 0.12% | -41.7% |
| Q3 2017 | $4,537,000 | +19.6% | 817,435 | 0.0% | 0.20% | +1.0% |
| Q2 2017 | $3,793,000 | -6.3% | 817,435 | 0.0% | 0.20% | +29.5% |
| Q1 2017 | $4,046,000 | -70.4% | 817,435 | -33.7% | 0.16% | -72.3% |
| Q4 2016 | $13,685,000 | +13.1% | 1,232,844 | -5.7% | 0.56% | 0.0% |
| Q3 2016 | $12,103,000 | +48.7% | 1,307,058 | +1.9% | 0.56% | +75.9% |
| Q2 2016 | $8,141,000 | +31.6% | 1,282,058 | +35.1% | 0.32% | +21.7% |
| Q1 2016 | $6,187,000 | -19.6% | 948,934 | 0.0% | 0.26% | -15.7% |
| Q4 2015 | $7,696,000 | +10.6% | 948,934 | 0.0% | 0.31% | +16.0% |
| Q3 2015 | $6,956,000 | -28.5% | 948,934 | 0.0% | 0.27% | -17.0% |
| Q2 2015 | $9,727,000 | +54.7% | 948,934 | +39.6% | 0.32% | +58.8% |
| Q1 2015 | $6,287,000 | +20.4% | 679,627 | -8.8% | 0.20% | +8.5% |
| Q4 2014 | $5,221,000 | +114.6% | 744,799 | +66.8% | 0.19% | +111.2% |
| Q3 2014 | $2,433,000 | – | 446,452 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| NATIONS FINANCIAL GROUP INC, /IA/ /ADV | 20,150 | $0 | 0.00% |
| Advisory Services Network, LLC | 2,233 | $0 | 0.00% |
| Fernwood Investment Management, LLC | 34,000 | $0 | 0.00% |